Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs AFLAC Incorporated (AFL) Price & Performance

AbCellera Biologics IncTrade
AFLAC IncorporatedTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs AFLAC Incorporated — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while AFLAC Incorporated trades at $121.06 (market cap $60.70B). The key difference: AFLAC Incorporated is far larger — about 20.3× AbCellera Biologics Inc's market cap, and AFLAC Incorporated pays a 2.02% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLAFL
Market Cap
$2.99B$60.70B
Sector
HealthFinancials
52-Week High
$9.76$129.55
52-Week Low
$2.78$103.55
Enterprise Value
$2.58B$70.65B
Dividend Yield
2.02%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About AFLAC Incorporated

Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.

Read more on AFL